A citation-based method for searching scientific literature

Ying Pang, Yanxin Lu, Veronika Caisova, Yang Liu, Petra Bullova, Thanh-Truc Huynh, Yiqiang Zhou, Di Yu, Zdenek Frysak, Igor Hartmann, David Taïeb, Karel Pacak, Chunzhang Yang. Clin Cancer Res 2018
Times Cited: 42







List of co-cited articles
552 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma.
Lauren Fishbein, Ignaty Leshchiner, Vonn Walter, Ludmila Danilova, A Gordon Robertson, Amy R Johnson, Tara M Lichtenberg, Bradley A Murray, Hans K Ghayee, Tobias Else,[...]. Cancer Cell 2017
340
59

SDH mutations establish a hypermethylator phenotype in paraganglioma.
Eric Letouzé, Cosimo Martinelli, Céline Loriot, Nelly Burnichon, Nasséra Abermil, Chris Ottolenghi, Maxime Janin, Mélanie Menara, An Thach Nguyen, Paule Benit,[...]. Cancer Cell 2013
461
42

SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma.
Julien Hadoux, Judith Favier, Jean-Yves Scoazec, Sophie Leboulleux, Abir Al Ghuzlan, Caroline Caramella, Désirée Déandreis, Isabelle Borget, Céline Loriot, Cécile Chougnet,[...]. Int J Cancer 2014
104
40

Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas.
Laurence Amar, Eric Baudin, Nelly Burnichon, Séverine Peyrard, Stéphane Silvera, Jérôme Bertherat, Xavier Bertagna, Martin Schlumberger, Xavier Jeunemaitre, Anne-Paule Gimenez-Roqueplo,[...]. J Clin Endocrinol Metab 2007
289
38

Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
Jacques W M Lenders, Quan-Yang Duh, Graeme Eisenhofer, Anne-Paule Gimenez-Roqueplo, Stefan K G Grebe, Mohammad Hassan Murad, Mitsuhide Naruse, Karel Pacak, William F Young. J Clin Endocrinol Metab 2014
35

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.
Mary A Selak, Sean M Armour, Elaine D MacKenzie, Houda Boulahbel, David G Watson, Kyle D Mansfield, Yi Pan, M Celeste Simon, Craig B Thompson, Eyal Gottlieb. Cancer Cell 2005
35


Genetic testing in pheochromocytoma or functional paraganglioma.
Laurence Amar, Jérôme Bertherat, Eric Baudin, Christiane Ajzenberg, Brigitte Bressac-de Paillerets, Olivier Chabre, Bernard Chamontin, Brigitte Delemer, Sophie Giraud, Arnaud Murat,[...]. J Clin Oncol 2005
466
30


Treatment of malignant pheochromocytoma/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients.
Hui Huang, Jame Abraham, Elizabeth Hung, Steven Averbuch, Maria Merino, Seth M Steinberg, Karel Pacak, Tito Fojo. Cancer 2008
141
28

Genomic Landscape of Pheochromocytoma and Paraganglioma.
Ivana Jochmanova, Karel Pacak. Trends Cancer 2018
46
28

Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair.
Parker L Sulkowski, Ranjini K Sundaram, Sebastian Oeck, Christopher D Corso, Yanfeng Liu, Seth Noorbakhsh, Monica Niger, Marta Boeke, Daiki Ueno, Aravind Nambiar Kalathil,[...]. Nat Genet 2018
92
28

Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma.
Nelly Burnichon, Laure Vescovo, Laurence Amar, Rossella Libé, Aurélien de Reynies, Annabelle Venisse, Elodie Jouanno, Ingrid Laurendeau, Béatrice Parfait, Jérôme Bertherat,[...]. Hum Mol Genet 2011
206
28

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study.
Segolene Hescot, Maria Curras-Freixes, Timo Deutschbein, Anouk van Berkel, Delphine Vezzosi, Laurence Amar, Christelle de la Fouchardière, Nuria Valdes, Fernando Riccardi, Christine Do Cao,[...]. J Clin Endocrinol Metab 2019
62
28

Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas.
Montserrat Ayala-Ramirez, Cecile N Chougnet, Mouhammed Amir Habra, J Lynn Palmer, Sophie Leboulleux, Maria E Cabanillas, Caroline Caramella, Pete Anderson, Abir Al Ghuzlan, Steven G Waguespack,[...]. J Clin Endocrinol Metab 2012
122
26

Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas.
Luis Jaime Castro-Vega, Alexandre Buffet, Aguirre A De Cubas, Alberto Cascón, Mélanie Menara, Emmanuel Khalifa, Laurence Amar, Sharona Azriel, Isabelle Bourdeau, Olivier Chabre,[...]. Hum Mol Genet 2014
244
26


Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma.
B E Baysal, R E Ferrell, J E Willett-Brozick, E C Lawrence, D Myssiorek, A Bosch, A van der Mey, P E Taschner, W S Rubinstein, E N Myers,[...]. Science 2000
26


Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma.
Grace Kong, Simona Grozinsky-Glasberg, Michael S Hofman, Jason Callahan, Amichay Meirovitz, Ofra Maimon, David A Pattison, David J Gross, Rodney J Hicks. J Clin Endocrinol Metab 2017
84
23

Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.
Luis Jaime Castro-Vega, Eric Letouzé, Nelly Burnichon, Alexandre Buffet, Pierre-Hélie Disderot, Emmanuel Khalifa, Céline Loriot, Nabila Elarouci, Aurélie Morin, Mélanie Menara,[...]. Nat Commun 2015
125
23

Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.
Judith Favier, Laurence Amar, Anne-Paule Gimenez-Roqueplo. Nat Rev Endocrinol 2015
281
23

Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma.
D Astuti, F Latif, A Dallol, P L Dahia, F Douglas, E George, F Sköldberg, E S Husebye, C Eng, E R Maher. Am J Hum Genet 2001
816
23

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
Francien H van Nederveen, José Gaal, Judith Favier, Esther Korpershoek, Rogier A Oldenburg, Elly M C A de Bruyn, Hein F B M Sleddens, Pieter Derkx, Julie Rivière, Hilde Dannenberg,[...]. Lancet Oncol 2009
367
23

A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial.
Grainne M O'Kane, Shereen Ezzat, Anthony M Joshua, Isabelle Bourdeau, Raya Leibowitz-Amit, Harold J Olney, Monika Krzyzanowska, Dean Reuther, Soo Chin, Lisa Wang,[...]. Br J Cancer 2019
38
26

Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
P J Pollard, J J Brière, N A Alam, J Barwell, E Barclay, N C Wortham, T Hunt, M Mitchell, S Olpin, S J Moat,[...]. Hum Mol Genet 2005
634
21

Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia.
Zhengping Zhuang, Chunzhang Yang, Felipe Lorenzo, Maria Merino, Tito Fojo, Electron Kebebew, Vera Popovic, Constantine A Stratakis, Josef T Prchal, Karel Pacak. N Engl J Med 2012
260
21

Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas.
Lauren Fishbein, Sanika Khare, Bradley Wubbenhorst, Daniel DeSloover, Kurt D'Andrea, Shana Merrill, Nam Woo Cho, Roger A Greenberg, Tobias Else, Kathleen Montone,[...]. Nat Commun 2015
112
21

Recurrent Mutations of Chromatin-Remodeling Genes and Kinase Receptors in Pheochromocytomas and Paragangliomas.
Rodrigo A Toledo, Yuejuan Qin, Zi-Ming Cheng, Qing Gao, Shintaro Iwata, Gustavo M Silva, Manju L Prasad, I Tolgay Ocal, Sarika Rao, Neil Aronin,[...]. Clin Cancer Res 2016
81
21

SDHA is a tumor suppressor gene causing paraganglioma.
Nelly Burnichon, Jean-Jacques Brière, Rossella Libé, Laure Vescovo, Julie Rivière, Frédérique Tissier, Elodie Jouanno, Xavier Jeunemaitre, Paule Bénit, Alexander Tzagoloff,[...]. Hum Mol Genet 2010
477
21

Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Hartmut P H Neumann, Christian Pawlu, Mariola Peczkowska, Birke Bausch, Sarah R McWhinney, Mihaela Muresan, Mary Buchta, Gerlind Franke, Joachim Klisch, Thorsten A Bley,[...]. JAMA 2004
662
21

Germline Mutations in the Mitochondrial 2-Oxoglutarate/Malate Carrier SLC25A11 Gene Confer a Predisposition to Metastatic Paragangliomas.
Alexandre Buffet, Aurélie Morin, Luis-Jaime Castro-Vega, Florence Habarou, Charlotte Lussey-Lepoutre, Eric Letouzé, Hervé Lefebvre, Isabelle Guilhem, Magalie Haissaguerre, Isabelle Raingeard,[...]. Cancer Res 2018
70
21

Phase II trial of pazopanib in advanced/progressive malignant pheochromocytoma and paraganglioma.
Sina Jasim, Vera J Suman, Camilo Jimenez, Pamela Harris, Kostandinos Sideras, Jill K Burton, Francis Paul Worden, Richard J Auchus, Keith C Bible. Endocrine 2017
32
25

Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene.
Alberto Cascón, Iñaki Comino-Méndez, María Currás-Freixes, Aguirre A de Cubas, Laura Contreras, Susan Richter, Mirko Peitzsch, Veronika Mancikova, Lucía Inglada-Pérez, Andrés Pérez-Barrios,[...]. J Natl Cancer Inst 2015
118
19


CHARACTERISTICS AND OUTCOMES OF METASTATIC SDHB AND SPORADIC PHEOCHROMOCYTOMA/PARAGANGLIOMA: AN NATIONAL INSTITUTES OF HEALTH STUDY.
Hana Turkova, Tamara Prodanov, Marek Maly, Victoria Martucci, Karen Adams, Jiri Widimsky, Clara C Chen, Alexander Ling, Electron Kebebew, Constantine A Stratakis,[...]. Endocr Pract 2016
70
19


Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas/paragangliomas.
Do-Youn Oh, Tae-Won Kim, Young Suk Park, Sang Joon Shin, Seong Hoon Shin, Eun-Kee Song, Hyo Jin Lee, Kewn-Wook Lee, Yung-Jue Bang. Cancer 2012
58
19

SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).
Thomas G Papathomas, Lindsey Oudijk, Alexandre Persu, Anthony J Gill, Francien van Nederveen, Arthur S Tischler, Frédérique Tissier, Marco Volante, Xavier Matias-Guiu, Marcel Smid,[...]. Mod Pathol 2015
121
19

Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism.
Charlotte Lussey-Lepoutre, Kate E R Hollinshead, Christian Ludwig, Mélanie Menara, Aurélie Morin, Luis-Jaime Castro-Vega, Seth J Parker, Maxime Janin, Cosimo Martinelli, Chris Ottolenghi,[...]. Nat Commun 2015
124
19

Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer-Predisposing Mutations in Pheochromocytomas and Paragangliomas.
Laura Remacha, Iñaki Comino-Méndez, Susan Richter, Laura Contreras, María Currás-Freixes, Guillermo Pita, Rocío Letón, Antonio Galarreta, Rafael Torres-Pérez, Emiliano Honrado,[...]. Clin Cancer Res 2017
42
19

Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma.
Sylvie Job, Irena Draskovic, Nelly Burnichon, Alexandre Buffet, Jérôme Cros, Charles Lépine, Annabelle Venisse, Estelle Robidel, Virginie Verkarre, Tchao Meatchi,[...]. Clin Cancer Res 2019
53
19

Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies.
Ying Pang, Yang Liu, Karel Pacak, Chunzhang Yang. Cancers (Basel) 2019
22
36

Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years.
Oksana Hamidi, William F Young, Nicole M Iñiguez-Ariza, Nana Esi Kittah, Lucinda Gruber, Cristian Bancos, Shrikant Tamhane, Irina Bancos. J Clin Endocrinol Metab 2017
130
19

Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma.
Alejandro Roman-Gonzalez, Shouhao Zhou, Montserrat Ayala-Ramirez, Chan Shen, Steven G Waguespack, Mouhammed A Habra, Jose A Karam, Nancy Perrier, Christopher G Wood, Camilo Jimenez. Ann Surg 2018
41
17


(131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis.
L T van Hulsteijn, N D Niemeijer, O M Dekkers, E P M Corssmit. Clin Endocrinol (Oxf) 2014
93
16

Targeting renal cell carcinoma with a HIF-2 antagonist.
Wenfang Chen, Haley Hill, Alana Christie, Min Soo Kim, Eboni Holloman, Andrea Pavia-Jimenez, Farrah Homayoun, Yuanqing Ma, Nirav Patel, Paul Yell,[...]. Nature 2016
384
16

Targeting IDH1-Mutated Malignancies with NRF2 Blockade.
Yang Liu, Yanxin Lu, Orieta Celiku, Aiguo Li, Qixin Wu, Yiqiang Zhou, Chunzhang Yang. J Natl Cancer Inst 2019
43
16

Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair.
Yanxin Lu, Jakub Kwintkiewicz, Yang Liu, Katherine Tech, Lauren N Frady, Yu-Ting Su, Wendy Bautista, Seog In Moon, Jeffrey MacDonald, Matthew G Ewend,[...]. Cancer Res 2017
115
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.